Eligard (leuprolide acetate) is usually given as a long-term therapy for the treatment of advanced prostate cancer. Hormone therapy may be continued for as long as the treatment continues to be beneficial and the side effects are tolerated. Studies have shown that continuation of therapy with leuprolide acetate maintains testosterone below the castrate level for up to seven years.